Regulatory Perspectives on Pharmacogenomics explores the legal and regulatory frameworks governing pharmacogenomic applications. It covers guidelines from agencies like the FDA and EMA regarding genetic testing and personalized therapies. The book discusses challenges in regulatory approvals, ethical considerations, and compliance standards. Ideal for regulatory affairs professionals and policymakers, it provides a thorough overview of the regulatory landscape in pharmacogenomics.
Catherine Rogers specializes in the regulatory aspects of pharmacogenomics, ensuring compliance and safety in its application within dermatology. Her research focuses on navigating the legal frameworks and standards governing pharmacogenomic testing and personalized therapies. Catherine has published extensively on the regulatory requirements for implementing pharmacogenomic strategies in clinical practice. She also provides guidelines for clinicians and researchers to adhere to regulatory standards when adopting pharmacogenomic approaches, promoting safe and compliant personalized dermatological care through informed regulatory practices.